Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
PR Newswire

RADI Medical Systems Launches Next Generation PressureWire(R) Certus

— UPPSALA, Sweden, July 8

UPPSALA, Sweden, July 8 /PRNewswire/ -- RADI Medical Systems today announced improvements to their latest generation pressure sensing guide wire, PressureWire(R) Certus, which will begin shipments immediately.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080708/311790 )

The latest generation of the PressureWire(R) Certus features a new ergonomically designed proximal connector which provides three key advantages for physicians. The new large entry funnel allows for fast and easy wire reconnection into the proximal connector, while also exhibiting less insertion friction. In addition, the new locking cap provides positive reinforcement when the wire and the connector are locked in place via a user intuitive on and off twist function.

"The updated PressureWire(R) Certus is another step forward in ease of use," commented Nico Pijls, MD, Department of Cardiology at Catharina Hospital, Eindhoven, the Netherlands. "I am pleased that improvements to PressureWire(R) Certus occur frequently to assist in measuring FFR in more challenging anatomy, such as we faced in the recently completed FAME study (Fractional flow reserve vs. Angiography for Multivessel Evaluation). In this multicenter randomized trial involving 1000 patients, FFR was measured in 3 arteries per patient using PressureWire(R). Successful, unequivocally interpretable measurement could be achieved in 99.3% of all coronary arteries thanks to recent improvements to the PressureWire(R)."

The PressureWire(R) Certus is used in the assessment of Fractional Flow Reserve (FFR). FFR expresses the maximum achievable blood flow in a coronary artery with abnormal stenosis as a fraction of maximum blood flow in the absence of a stenosis. FFR is 100% specific in identifying which lesions are actually causing the flow restriction and may be treated.

"Radi continues to make improvements to the PressureWire(R) to improve product performance, and ultimately patient care," commented Jason Rudy, Director of Marketing of Radi Medical Systems, Inc. "This is a further improvement to PressureWire(R) Certus which has already received impressive physician performance feedback."

About Radi Medical Systems AB

Radi Medical Systems AB (Radi) develops, manufactures and sells medical devices designed to improve patient care. The company's pioneering work in the field of interventional cardiology has resulted in market-leading intravascular sensors and hemostasis management and radiology devices. Radi works closely with medical practitioners to develop solutions that address clinical needs, as well as provide clinical education support. Founded in 1988, Radi employs more than 380 people globally and has representation in more than 40 countries. The company is based in Uppsala, Sweden, and maintains a U.S. headquarters in Wilmington, MA. For more information, visit http://www.radi.se.

Related Pharmalicensing company profiles

Related news

Partnering consultation free of charge
The countdown has started...
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us